CYDY - Therapeutics For Jun 2020
Among Covid-19 therapeutic drugs (not vaccines) with the most advanced trials that would make news within the next weeks appears to be Cytodyn-CYDY (leading the list) MESO, ATHX, HGEN. Cytodyn has made an statement anouncing the unblinding on June 15th, 2020 of Leronlimab results on fase 2b/3 trial for Covid-19. The key point seems to be that those trials are also running for brand positioning of CYDY`s drug Leronlimab that has an impresive track record as a therapeutic that is extensive for the treatment of other different diseases that make it unique.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.